Every patient in the trial has met the primary safety endpoint, confirmed through PET imaging showing precise retention of the therapeutic Yttrium-90 isotope at the injection site—with no observed ...

Sarepta (SRPT) shared updates from its clinical programs focused on limb-girdle muscular dystrophy subtypes 2C/R5, 2D/R3, and 2E/R4. Following ...

Daily treatment with IPL344 for up to three years was safe and slowed ALS progression in a small Phase 2a clinical trial, ...

Researchers presented a first study on biological pathways perturbed in association with CRCI, anxiety, and co-occurring CRCI.

Edaravone may exert its neuroprotective effects in ALS by also correcting the abnormal localization of TDP-43, a key ...

The Systemic Foundation Level pathway aims to provide students with an understanding of the main concepts and practices in systems theory and therapy, as well as systemic research. Theoretical ...

Credit: MUNGKHOOD STUDIO/Shutterstock. Clinical research organisation (CRO) ICON has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes ICON the ...

“ICON leads in risk-based quality management, integrating Data Management and Central Monitoring teams in our Clinical Data Science group. To meet growing data demands and customer expectations ...

Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, 2025 ...

The integration of Clinical Data Studio into ICON’s service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, ...

The primary outcome of the trial was time to correct treatment (TTCT). 22 The study’s novel aspects included the randomised comparison of clinical pathways, rather than comparing the sensitivity and ...